Trial Profile
A Randomized Phase II Study of Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin in the Preoperative Treatment of Locally Advanced Rectal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Bevacizumab; Capecitabine
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- Acronyms AXE-BEAM; AXEBeam
- 09 Jul 2019 Status changed from active, no longer recruiting to completed.
- 02 May 2017 Planned End Date changed from 1 Jul 2016 to 1 Mar 2019.
- 20 Jul 2016 Status changed from active, no longer recruiting to completed.